He obtained his MD from the University of Pennsylvania School of Medicine and did residency training in internal medicine at the Massachusetts General Hospital. He then completed fellowship training in Hematology and Oncology at the Dana-Farber Cancer Institute/Partners CancerCare Fellowship program. His translational research focuses on the role of vascular ephrinB2 signaling in controlling tumor immune microenvironments.